Results Healthcare   |   Results International

Insights

We add value by understanding our sectors inside out, and release regular industry research and reports

Results Healthcare has advised SQN Clinical on its acquisition by Veristat

By Kevin Bottomley, Kunal Kadiwar 26 Feb 2021

Results Healthcare is pleased to announce that it has advised SQN Clinical, one of the largest data focused specialty contract research companies in Europe, on its acquisition by Veristat, a scientific-minded global clinical research organisation headquartered in the US.

SQN Clinical successfully supports the needs of global pharmaceutical, biotechnology, medical device, and animal health partners with innovative clinical development capabilities including a full spectrum of trial, data, and project management solutions powered by robust statistical analysis and reporting. The acquisition adds more than 80 employees, increasing Veristat’s European footprint and bolstering one of Veristat’s most sought after service areas, solidifying its position as a premier provider of world class biometrics solutions.

This transaction further cements the firm’s position as the leading advisor to fast-growth CRO businesses having recently advised Charterhouse on its investment in Phastar and AdmeScope on its acquisition by MercachemSyncom.

Karen Grover, Director of SQN Clinical:

The acquisition by Veristat enhances our capabilities and services to proactively address the increased demand from our sponsors. We have a shared reputation for scientific excellence and a shared passion for teamwork to support consistent service delivery and the highest quality outcomes.

 

Our expertise in the CRO sector

 

Kevin Bottomley

Partner

Contact Kevin

Kunal Kadiwar

Managing Director

Contact Kunal

Insights

Regular Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office